Skip to main content
Screener/Healthcare/Biotechnology

FATE — Fate Therapeutics, Inc.

NASDAQ
$2.33-0.10 (-3.91%)
Micro CapPenny StockUnder $5Healthcare
$0.91
$2.46
$2.32
$2.46
EPS (TTM)$-1.15
P/E Ratio-1.13
Dividend Yield—
Market Cap$274.4M
Volume2.09M
Prev Close$2.43
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$1.4M-$32.4M$-0.27-842.4%-2364.8%
Q3 '25$1.7M-$32.3M$-0.27100.0%-1852.4%
Q2 '25$1.9M-$34.1M$-0.29100.0%-1786.6%
Q1 '25$1.6M-$37.6M$-0.32100.0%-2309.5%
Q4 '24$1.9M-$52.2M$-0.44100.0%-2803.9%
Q3 '24$3.1M-$47.7M$-0.40100.0%-1551.0%
Q2 '24$6.8M-$38.4M$-0.3330.3%-567.4%
Q1 '24$1.9M-$48.0M$-0.47-150.4%-2493.7%
Get Your Daily Market Recap